0	1	[	[	(
1	19	Molecular-biologic	molecular-biologic	JJ
20	27	aspects	aspect	NNS
28	30	of	of	IN
31	42	interaction	interaction	NN
43	50	between	between	IN
51	58	nervous	nervous	JJ
59	62	and	and	CC
63	69	immune	immune	JJ
70	77	systems	system	NNS
77	78	]	]	)
80	83	The	the	DT
84	91	problem	problem	NN
92	94	of	of	IN
95	98	the	the	DT
99	111	neuro-immuno	neuro-immuno	JJ
112	124	interactions	interaction	NNS
125	127	on	on	IN
128	131	the	the	DT
132	137	level	level	NN
138	140	of	of	IN
141	144	the	the	DT
145	152	protein	protein	NN
153	166	trans-factors	trans-factor	NNS
166	167	,	,	,
168	179	stimulating	stimulate	VBG
180	193	interleukin-2	interleukin-2	NN
194	195	(	(	(
195	199	IL-2	il-2	NN
199	200	)	)	)
201	205	gene	gene	NN
206	216	expression	expression	NN
217	220	was	be	VBD
221	230	discussed	discuss	VBN
230	231	.	.	.

232	235	The	the	DT
236	252	physico-chemical	physico-chemical	JJ
253	256	and	and	CC
257	267	functional	functional	JJ
268	278	parameters	parameter	NNS
279	281	of	of	IN
282	285	the	the	DT
286	289	low	low	JJ
290	299	molecular	molecular	JJ
300	307	nuclear	nuclear	JJ
308	316	proteins	protein	NNS
317	318	(	(	(
318	320	SP	SP	NNP
321	324	and	and	CC
325	328	BP-	BP-	NNP
329	331	14	14	CD
331	332	,	,	,
333	335	18	18	CD
335	336	,	,	,
337	339	19	19	CD
340	343	kDs	kd	NNS
343	344	)	)	)
345	353	isolated	isolate	VBN
354	358	from	from	IN
359	366	splenic	splenic	JJ
367	370	and	and	CC
371	376	brain	brain	NN
377	382	cells	cell	NNS
383	385	of	of	IN
386	395	immunized	immunize	VBN
396	400	rats	rat	NNS
401	405	were	be	VBD
406	413	studied	study	VBN
413	414	.	.	.

415	418	The	the	DT
419	426	binding	binding	NN
427	429	of	of	IN
430	435	these	these	DT
436	444	proteins	protein	NNS
445	447	to	to	TO
448	451	the	the	DT
452	462	regulatory	regulatory	JJ
463	469	region	region	NN
470	472	of	of	IN
473	477	IL-2	il-2	NN
478	482	gene	gene	NN
483	485	in	in	FW
486	491	vitro	vitro	FW
492	495	and	and	CC
496	507	stimulation	stimulation	NN
508	510	of	of	IN
511	514	the	the	DT
515	523	IL-2mRNA	IL-2mRNA	NNP
524	533	synthesis	synthesis	NN
534	536	in	in	IN
537	544	splenic	splenic	JJ
545	558	T-lymphocytes	t-lymphocyte	NNS
559	566	culture	culture	NN
567	569	in	in	IN
570	576	normal	normal	JJ
577	587	conditions	condition	NNS
588	592	were	be	VBD
593	598	shown	show	VBN
598	599	.	.	.

600	603	The	the	DT
604	614	protective	protective	JJ
615	621	effect	effect	NN
622	624	of	of	IN
625	627	SP	SP	NNP
628	631	and	and	CC
632	634	BP	BP	NNP
635	637	on	on	IN
638	641	the	the	DT
642	650	IL-2mRNA	IL-2mRNA	NNP
651	660	synthesis	synthesis	NN
661	663	in	in	IN
664	673	stressful	stressful	JJ
674	684	conditions	condition	NNS
685	688	and	and	CC
689	691	by	by	IN
692	695	the	the	DT
696	703	T-cells	T-cell	NNP
704	713	treatment	treatment	NN
714	718	with	with	IN
719	722	the	the	DT
723	726	CsA	CsA	NNP
727	730	was	be	VBD
731	743	demonstrated	demonstrate	VBN
743	744	.	.	.